275 related articles for article (PubMed ID: 12593623)
21. Growth patterns of pituitary adenomas and histopathological correlates.
Monsalves E; Larjani S; Loyola Godoy B; Juraschka K; Carvalho F; Kucharczyk W; Kulkarni A; Mete O; Gentili F; Ezzat S; Zadeh G
J Clin Endocrinol Metab; 2014 Apr; 99(4):1330-8. PubMed ID: 24423330
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and growth fractions of pituitary adenomas.
Yonezawa K; Tamaki N; Kokunai T
Surg Neurol; 1997 Nov; 48(5):494-500. PubMed ID: 9352815
[TBL] [Abstract][Full Text] [Related]
23. Gender-related differences in non-functioning pituitary adenomas.
Schaller B
Neuro Endocrinol Lett; 2003 Dec; 24(6):425-30. PubMed ID: 15073569
[TBL] [Abstract][Full Text] [Related]
24. Cavernous sinus invasion and tumor proliferative potential of growth hormone-producing pituitary tumors.
Iuchi S; Saeki N; Uchino Y; Higuchi Y; Tatsuno I; Nakamura S; Yasuda T; Yamaura A
Endocr J; 2000 Mar; 47 Suppl():S77-9. PubMed ID: 10890190
[TBL] [Abstract][Full Text] [Related]
25. Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.
Øystese KA; Zucknick M; Casar-Borota O; Ringstad G; Bollerslev J
Endocrine; 2017 Jul; 57(1):35-45. PubMed ID: 28516382
[TBL] [Abstract][Full Text] [Related]
26. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma.
Ikeda H; Jokura H; Yoshimoto T
J Neurosurg; 2001 Aug; 95(2):285-91. PubMed ID: 11780899
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis.
Wowra B; Stummer W
J Neurosurg; 2002 Dec; 97(5 Suppl):429-32. PubMed ID: 12507069
[TBL] [Abstract][Full Text] [Related]
28. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
[TBL] [Abstract][Full Text] [Related]
29. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
[TBL] [Abstract][Full Text] [Related]
30. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
[TBL] [Abstract][Full Text] [Related]
31. [The usefulness of adjuvant therapy using gamma knife radiosurgery for the recurrent or residual nonfunctioning pituitary adenomas].
Iwai Y; Yamanaka K; Yoshioka K; Yoshimura M; Honda Y; Matsusaka Y; Komiyama M; Yasui T
No Shinkei Geka; 2005 Aug; 33(8):777-83. PubMed ID: 16095207
[TBL] [Abstract][Full Text] [Related]
32. Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas.
Mahmoud OM; Tominaga A; Amatya VJ; Ohtaki M; Sugiyama K; Sakoguchi T; Kinoshita Y; Takeshima Y; Abe N; Akiyama Y; El-Ghoriany AI; Abd Alla AK; El-Sharkawy MA; Arita K; Kurisu K; Yamasaki F
Eur J Radiol; 2011 Nov; 80(2):412-7. PubMed ID: 20580505
[TBL] [Abstract][Full Text] [Related]
33. Implications of the World Health Organization definition of atypia on surgically treated functional and non-functional pituitary adenomas.
Sarkar S; Philip VJ; Cherukuri SK; Chacko AG; Chacko G
Acta Neurochir (Wien); 2017 Nov; 159(11):2179-2186. PubMed ID: 28573325
[TBL] [Abstract][Full Text] [Related]
34. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
35. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.
Balogun JA; Monsalves E; Juraschka K; Parvez K; Kucharczyk W; Mete O; Gentili F; Zadeh G
Endocr Pathol; 2015 Mar; 26(1):63-70. PubMed ID: 25403448
[TBL] [Abstract][Full Text] [Related]
36. Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis.
Chen Y; Wang CD; Su ZP; Chen YX; Cai L; Zhuge QC; Wu ZB
Neuroendocrinology; 2012; 96(4):333-42. PubMed ID: 22687984
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological analysis of nonfunctioning pituitary adenomas in patients younger than 25 years of age.
Yamaguchi-Okada M; Inoshita N; Nishioka H; Fukuhara N; Yamada S
J Neurosurg Pediatr; 2012 May; 9(5):511-6. PubMed ID: 22546029
[TBL] [Abstract][Full Text] [Related]
38. Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody.
Pizarro CB; Oliveira MC; Coutinho LB; Ferreira NP
Braz J Med Biol Res; 2004 Feb; 37(2):235-43. PubMed ID: 14762579
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]